NASDAQ:PETSPetmed Express Stock Price, Forecast & News

Petmed Express' stock was trading at $25.95 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PETS stock has increased by 25.4% and is now trading at $32.54.
View which stocks have been most impacted by COVID-19.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Petmed Express.

Petmed Express is scheduled to release its next quarterly earnings announcement on Monday, October 19th 2020.
View our earnings forecast for Petmed Express.

Petmed Express Inc (NASDAQ:PETS) issued its earnings results on Monday, July, 20th. The company reported $0.39 earnings per share for the quarter, missing the consensus estimate of $0.40 by $0.01. The firm had revenue of $96.20 million for the quarter, compared to analyst estimates of $90.96 million. Petmed Express had a return on equity of 21.91% and a net margin of 9.41%. Petmed Express's quarterly revenue was up 20.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.26 earnings per share.
View Petmed Express' earnings history.

Petmed Express declared a quarterly dividend on Monday, July 20th. Stockholders of record on Friday, July 31st will be paid a dividend of $0.28 per share on Friday, August 7th. This represents a $1.12 annualized dividend and a dividend yield of 3.44%. The ex-dividend date is Thursday, July 30th.
View Petmed Express' dividend history.

2 brokerages have issued 12-month target prices for Petmed Express' stock. Their forecasts range from $20.00 to $31.00. On average, they anticipate Petmed Express' share price to reach $25.50 in the next twelve months. This suggests that the stock has a possible downside of 21.6%.
View analysts' price targets for Petmed Express.

Press coverage about PETS stock has trended neutral recently, according to InfoTrie. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Petmed Express earned a media sentiment score of 0.2 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term.
View the latest news about Petmed Express.

Petmed Express saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 5,350,000 shares, an increase of 27.4% from the April 30th total of 4,200,000 shares. Based on an average daily trading volume, of 651,900 shares, the days-to-cover ratio is presently 8.2 days. Currently, 27.5% of the company's stock are sold short.
View Petmed Express' Short Interest.

Some companies that are related to Petmed Express include Amazon.com (AMZN), Netflix (NFLX), Booking (BKNG), Expedia Group (EXPE), Overstock.com (OSTK), Tripadvisor (TRIP), 1-800-Flowers.Com (FLWS), Shutterfly (SFLY), Groupon (GRPN) and U.S. Auto Parts Network (PRTS).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Petmed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Gilead Sciences (GILD), Alibaba Group (BABA), Cisco Systems (CSCO), Netflix (NFLX), Micron Technology (MU), Verizon Communications (VZ) and Advanced Micro Devices (AMD).

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

Petmed Express' stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.12%), Prudential Financial Inc. (2.10%), Man Group plc (2.02%), Bank of New York Mellon Corp (1.82%), Robeco Institutional Asset Management B.V. (1.74%) and Personal Capital Advisors Corp (1.51%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag and Robert C Schweitzer.
View institutional ownership trends for Petmed Express.

PETS stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Balyasny Asset Management LLC, Advisor Group Holdings Inc., Hancock Whitney Corp, Cairn Investment Group Inc., North Star Investment Management Corp., Principal Financial Group Inc., and Profit Investment Management LLC. Company insiders that have sold Petmed Express company stock in the last year include Bruce S Rosenbloom, Gian Fulgoni, and Menderes Akdag.
View insider buying and selling activity for Petmed Express.

PETS stock was acquired by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Prudential Financial Inc., Robeco Institutional Asset Management B.V., ProShare Advisors LLC, Raymond James Financial Services Advisors Inc., Jefferies Group LLC, AJO LP, and Mackay Shields LLC.
View insider buying and selling activity for Petmed Express.

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PETS stock can currently be purchased for approximately $32.54.

Petmed Express has a market capitalization of $659.65 million and generates $284.13 million in revenue each year. Petmed Express employs 187 workers across the globe.

The official website for Petmed Express is www.1800petmeds.com.

Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.